1. Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real‐world longitudinal data. (29th June 2021) Authors: Ravichandran, Sriram; Cohen, Oliver C.; Law, Steven; Sachchithanantham, Sajitha; Mahmood, Shameem; Foard, Darren; Fontana, Marianna; Martinez‐Naharro, Ana; Whelan, Carol; Gillmore, Julian D.; Lachmann, Helen J.; Hawkins, Philip N.; Wechalekar, Ashutosh D. Journal: British journal of haematology Issue: Volume 194:Number 3(2021) Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗